Loading…
Brawn Biotech (BSE 530207)₹21.90+4.04%Pharmaceuticals
At the end of the Jun 2026 quarter, Brawn Biotech's shareholders were: promoters 52.91%, DIIs 0.35%, public 46.74%. Promoter holding is unchanged on the quarter. 0.00% of promoter shares were pledged. It had 3,283 shareholders.
As of · Company filings (shareholding pattern)
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 53.69% | 53.69% | 53.61% | 53.61% | 53.61% | 53.61% | 53.63% | 53.63% | 53.63% | 53.36% | 52.91% | 52.91% |
| DIIs | 0.59% | 0.59% | 0.35% | 0.35% | 0.35% | 0.35% | 0.35% | 0.35% | 0.35% | 0.35% | 0.35% | 0.35% |
| Public | 45.72% | 45.72% | 46.04% | 46.04% | 46.04% | 46.04% | 46.02% | 46.02% | 46.02% | 46.29% | 46.74% | 46.74% |
| Promoter shares pledged | — | — | — | — | — | — | — | — | — | — | — | 0.00% |
| Number of shareholders | 6,193 | 6,138 | 4,159 | 4,089 | 4,156 | 4,059 | 4,023 | 3,974 | 3,957 | 3,443 | 3,302 | 3,283 |
| Holder | Category | Jun 2026 | Change (pp) |
|---|---|---|---|
| Brij Raj Gupta | Promoter | 16.71% | 0.00 |
| Investor Education And Protection Fund Authority | Public | 14.47% | 0.00 |
| Shashi Bala Gupta | Promoter | 8.29% | 0.00 |
| Nitin Gupta | Promoter | 6.51% | 0.00 |
| Brij Bala Gupta | Promoter | 6.35% | 0.00 |
| Adarsh Kumar Gupta | Promoter | 6.29% | 0.00 |
| Atul Gupta | Promoter | 2.35% | 0.00 |
| A B Pharma P Ltd | Promoter | 2.28% | 0.00 |
| Kavita Gupta | Promoter | 1.51% | 0.00 |
| Daksha Kotak | Public | 1.25% | 0.00 |
| Bhawna Goyal | Promoter | 0.99% | 0.00 |
| Mamta Gupta | Promoter | 0.44% | 0.00 |
| Kush Gupta | Promoter | 0.43% | 0.00 |
| Mamta Goel | Promoter | 0.36% | 0.00 |
| Nupur Vibhuti | Promoter | 0.08% | 0.00 |
| Surabhi Vibhuti | Promoter | 0.08% | 0.00 |
| Humaira Farooq | Promoter | 0.07% | 0.00 |
| Maneet Kaur Chhatwal | Promoter | 0.07% | 0.00 |
| Mohinder Singh Shah | Promoter | 0.07% | 0.00 |
| Pradip Prasad | Promoter | 0.07% | 0.00 |
| Shanta Bazaz | Promoter | 0.07% | 0.00 |
| Tilak Raj Nijhara | Promoter | 0.07% | 0.00 |
| Basant Kumar Goswami | Promoter | 0.05% | 0.00 |
Promoters held 52.91% of Brawn Biotech at the end of the Jun 2026 quarter, down 0.72 percentage points from 53.63% a year earlier.
In the Jun 2026 quarter, foreign institutional investors (FIIs) held no reported stake and domestic institutions (DIIs) held 0.35% (unchanged at 0.35% a quarter earlier).
No. The Jun 2026 filing shows no pledged promoter shares.
Brawn Biotech had 3,283 shareholders at the end of the Jun 2026 quarter, against 3,974 a year earlier.
Investor Education And Protection Fund Authority (Public) held 14.47% at the end of the Jun 2026 quarter, the largest named holding outside the promoter group.